comparemela.com
Home
Live Updates
NeuroSense Therapeutics to Present at the ALS Drug Development Summit in Boston on May 26, 2022 : comparemela.com
NeuroSense Therapeutics to Present at the ALS Drug Development Summit in Boston on May 26, 2022
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Edinburgh ,
City Of ,
Ferenc Tracik ,
Nedira Salzman Frenkel ,
Shiran Zimri ,
Linkedin ,
Company Head Of Scientific Program ,
Twitter ,
Prnewswire Neurosense Therapeutics Ltd ,
Drug Development Summit ,
Nasdaq ,
Neurosense Therapeutics Ltd ,
European Network To Cure ,
European Medicines Agency ,
Business Development ,
Combination Therapy ,
Target Complexity ,
Sense Therapeutics ,
Chief Medical Officer ,
Development Summit ,
Therapeutic Potential ,
Dissecting Exciting Opportunities ,
Drive Novel Therapeutic Strategies ,
Scientific Program ,
European Network ,
Massachusetts General Hospital ,
Neuron Derived Exosomes ,
Orphan Drug Designation ,
Neurosense ,
comparemela.com © 2020. All Rights Reserved.